发明授权
- 专利标题： 2,5-disubstituted arylsulfonamide CCR3 antagonists
- 专利标题（中）： 2,5-二取代芳基磺酰胺CCR3拮抗剂
-
申请号： US13846222申请日： 2013-03-18
-
公开(公告)号： US08669247B2公开(公告)日： 2014-03-11
- 发明人: Tai Wei Ly , Marie Chantal Siu-Ying Tran , Erik Dean Raaum
- 申请人： Tai Wei Ly , Marie Chantal Siu-Ying Tran , Erik Dean Raaum
- 申请人地址： US CA San Diego
- 专利权人： Axikin Pharmaceuticals, Inc.
- 当前专利权人： Axikin Pharmaceuticals, Inc.
- 当前专利权人地址： US CA San Diego
- 代理机构： Jones Day
- 主分类号： A61K31/551
- IPC分类号： A61K31/551 ; A61K31/445 ; A61K31/497 ; A61K31/4965
摘要：
Provided herein are 2,5-disubstituted arylsulfonamides that are useful for modulating CCR3 activity, and pharmaceutical compositions thereof. Also provided herein are methods of their use for treating, preventing, or ameliorating one or more symptoms of a CCR3-mediated disorder, disease, or condition.
公开/授权文献
- US20130225565A1 2,5-DISUBSTITUTED ARYLSULFONAMIDE CCR3 ANTAGONISTS 公开/授权日：2013-08-29